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Abstract
The Sertoli cells are critical regulators of testis differentiation and development. In the adult, however, their known function
is restricted largely to maintenance of spermatogenesis. To determine whether the Sertoli cells regulate other aspects of
adult testis biology we have used a novel transgenic mouse model in which Amh-Cre induces expression of the receptor for
Diphtheria toxin (iDTR) specifically within Sertoli cells. This causes controlled, cell-specific and acute ablation of the Sertoli
cell population in the adult animal following Diphtheria toxin injection. Results show that Sertoli cell ablation leads to rapid
loss of all germ cell populations. In addition, adult Leydig cell numbers decline by 75% with the remaining cells
concentrated around the rete and in the sub-capsular region. In the absence of Sertoli cells, peritubular myoid cell activity is
reduced but the cells retain an ability to exclude immune cells from the seminiferous tubules. These data demonstrate that,
in addition to support of spermatogenesis, Sertoli cells are required in the adult testis both for retention of the normal adult
Leydig cell population and for support of normal peritubular myoid cell function. This has implications for our
understanding of male reproductive disorders and wider androgen-related conditions affecting male health.
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Introduction
The Sertoli cells are essential regulators of testis differentiation
and fetal masculinization through expression of SRY, secretion of
AMH and induction of fetal Leydig cell development (reviewed in
[1–4]). In the adult, the primary functions of the Sertoli cells are to
provide a physical framework to support germ cell survival and
development (reviewed in [5]) and an appropriate environment to
ensure germ cell maturation [6,7]. The Sertoli cells also act
together with the peritubular myoid cells (PTMC) to lay down the
basement membrane surrounding the tubules [8]. It is currently
unknown, however, whether the Sertoli cells also act in the adult to
regulate the number and activity of other testicular somatic cell
types.
There is now increasing evidence to suggest that testosterone
levels in adult and ageing men are important for maintaining
wellbeing [9–14]. In men, testosterone is produced largely by the
testicular Leydig cells and as men age Leydig cell numbers are
reduced [15,16] and testosterone production per cell is also
reduced [17]. Establishing what controls Leydig cell maintenance
and function is therefore critical to understanding adult male
health and wellbeing. The population of Leydig cells that
maintains adult levels of testosterone develops after birth largely
under the control of luteinizing hormone (LH). In mice lacking LH
or the LH-receptor (LHCGR) adult Leydig cell numbers are about
10% of normal and testosterone levels are essentially undetectable
[18–20]. Recent studies from our lab have shown, however, that
the Sertoli cells are also essential for adult Leydig cell development
[21]. A role for the Sertoli cells in adult Leydig cell development
has also been suggested by Hazra and colleagues [22] who have
shown that precocious androgen receptor (AR) expression in the
Sertoli cells has knock-on effects on the Leydig cells. Once
established, however, the Leydig cell population is quite stable
through most of adulthood and cell division is very rare under
normal circumstances [23–25]. Even withdrawal of LH support,
while reducing testosterone production markedly, has little effect
on Leydig cell number [26,27]. It is not clear, therefore, whether
the Sertoli cells continue to play a role in regulating adult Leydig
cell maintenance or whether the Leydig cells are largely
autonomous, dependent only on hormonal regulation.
Use of controlled cell ablation to study development and
function has a long history of utility in testis biology. Studies using
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cytotoxins such as busulfan (for germ cell ablation) [28,29], and
ethane dimethane sulphonate (EDS) (for Leydig cell ablation in
rats) [30] have uncovered previously intractable aspects of testis
function. Similar studies to examine the effects of Sertoli cell
ablation on adult testis function have not been possible, however,
as cytotoxins that specifically target the Sertoli cells have not been
available. To address this need, we have developed a novel
transgenic mouse model that permits controlled and specific
ablation of Sertoli cells at any chosen age via Diptheria-toxin
(DTX)–mediated induction of apoptosis [21]. In this study we
show that specific and acute ablation of Sertoli cells in adulthood
causes loss of all germ cells, apart from elongated spermatids, and
a reduction in PTMC activity although the PTMC layer remains
effective at excluding immune cells from the lumen of the
seminiferous tubules. Most importantly, we also show for the first
time that, in addition to their established role in supporting
spermatogenesis, the Sertoli cells are critical for maintaining
Leydig cell numbers in the adult testis. These findings significantly
alter our understanding of adult testis function, with potential
implications for male reproductive and general health.
Materials and Methods
Ethics Statement
Mice were housed and bred under standard conditions of care.
Experiments passed local ethical review and were conducted with
licenced permission under the UK Animal Scientific Procedures
Act (1986), Home Office licence number PPL 60/4200.
Breeding of transgenic mice, Genotyping
Mice were generated as previously described [21] using the
Cre/Lox cell specific recombination system. Amh-Cre;iDTR,
Stra8-Cre;iDTR and the CSFR-GFP+/2 (MacGreen) mice bred to
Amh-Cre;iDTR mice were identified by genotyping from ear or
tail DNA for the presence of Cre and iDTR using standard PCR
with appropriate primers listed in Table S1. Inheritance of the
GFP transgene was also verified in the MacGreen cross-bred
animals. For the phenotypic study, matings were designed to
generate only homozygous Amh-Cre+/+;iDTR+/+, Mac-Green
and Stra8-Cre+/+;iDTR+/+. Adult animals (post-natal day 50:
pnd50) were treated with a single dose of DTX (100 ng) as
previously described [21].
Tissue collection
Animals were culled at different times after DTX injection (see
Figure 1C) by CO2 asphyxiation and subsequent cervical disloca-
tion. Blood was harvested by cardiac puncture for hormonal
profile analysis. Body weight and reproductive organs (testis and
seminal vesicle) weights were recorded. Collected tissues were
either fixed or frozen for RNA or protein analysis.
RNA isolation and real-time PCR
Testis RNA was extracted using Trizol (Life Technologies,
Paisley, UK) and levels of specific mRNA species were measured
by real-time PCR following reverse transcription of the isolated
RNA. Total RNA was reverse transcribed at 50uC using random
hexamers and Moloney murine leukaemia virus reverse transcrip-
tase (Superscript III, Life Technologies) as described previously
[31]. To allow specific mRNA levels to be expressed per testis and
to control for RNA extraction efficiency, RNA degradation, and
the reverse transcription step, 5 ng external standard (luciferase
mRNA: Promega UK, Southampton, UK) was added to each
testis at the start of the RNA extraction [32]. The real-time PCR
approach used the SYBR green method in a 96-well plate format
with a Stratagene MX3000 cycler. Reactions contained 5 ml
2xSYBR mastermix (Agilent Technologies, Wokingham, UK),
primers (100 nM) and template in a total volume of 10 ml and a
melting curve analysis was carried out on the products formed. All
primers were designed by Primer Express 2.0 (Applied Biosystems,
Warrington, UK) using parameters previously described [33] and
the primers used are described in Table S1. Transcript levels were
normalised relative to the luciferase external standard, which
generates a value of transcript expression per testis [34].
Immunostaining and Stereology and histology
Tissues were fixed in Bouins for 6 hours, stored in ethanol (70%)
and embeded in paraffin or in resin (see below). Tissue sections
(5 mm) were dewaxed in xylene then rehydrated in graded ethanol
solutions. For histology, slides were stained with Hemaetoxylin/
Eosin and Picrosirius Red using standard protocols. For immu-
nostaining, slides were subjected to antigen-retrieval in a pressure
cooker for 5 minutes with 0.01 M citrate buffer (pH 6.0). To
quench endogenous peroxidases activity, slides were incubated in
0.3% hydrogen peroxide (v/v) in Tris-buffered saline (TBS) for
30 minutes at room temperature (RT). Nonspecific activity was
blocked using the appropriate normal blocking serum (10%
normal serum (vol/vol; Biosera) and 5% BSA (wt/vol; Sigma-
Aldrich, Gillingham, UK) in TBS for 30 minutes at RT followed
by incubation overnight at 4uC with the primary antibody diluted
in blocking serum. The primary antibodies used in this study are
detailed in Table S2. After washing, slides were incubated for
30 minutes at RT with the appropriate secondary antibody. For
diaminobenzidine (DAB) visualisation, the secondary antibody was
conjugated to biotin and diluted 1/500 in the blocking serum. This
step was followed by incubation with horseradish peroxidase-
labeled avidin-biotin complex (VectorLabs, Peterborough, UK) for
30 minutes at RT then development in DAB (Immpact DAB;
VectorLabs, Peterborough, UK). Slides were counterstained with
haematoxylin, dehydrated and mounted with Pertex mounting
medium (Cell Path, Hemel Hempstead, UK). For immunofluo-
rescence, the secondary antibody was conjugated to peroxidase
and diluted 1/200 in blocking serum and left on the slides for
30 minutes at RT. Sections were then incubated with a fluorescein
Tyramide Signal Amplification system (‘TSA’, Perkin Elmer) for
10 minutes at RT according to the manufacturer’s instructions.
Sections were counterstained in Sytox Green (Molecular Probes,
life technologies, Paisley, UK) for 10 minutes at RT and mounted
in PermaFluor mounting medium (Thermo Scientific, UK).
Sections incubated with no primary antibody were used as
negative controls. To ensure reproducibility, 4 to 6 different
animals from each group were tested and sections from control
and DTX-treated animals were processed simultaneously on the
same slide.
For stereological analysis, testes were embedded in Technovit
7100 resin, cut into sections (20 mm), and stained with Harris’
hematoxylin. The total testis volume was estimated using the
Cavalieri principle [35]. The optical disector technique [36] was
used to count the number of Leydig cells in each testis. The cells
were recognised by their position, round nucleus and relatively
abundant cytoplasm as described previously [18,37–39]. After
DTX injection the morphology of some of the Leydig cells started
to change (e.g. reduction in cytoplasmic volume) as described in
Results. These cells were included in the Leydig cell count while
they maintained morphological features consistent with Leydig
cells. Immunohistochemical staining confirmed that only cells
morphologically-recognisable as Leydig cells stained with Leydig
cell markers (eg HSD3B) after DTX treatment. The numerical
density of Leydig cells was estimated using an Olympus BX50
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microscope fitted with a motorized stage (Prior Scientific
Instruments, Cambridge, UK) and Stereologer software (Systems
Planning Analysis, Alexandria, VA, USA). To illustrate testis
histology semi-thin 2.5 mm sections were cut from tissues
embedded in resin and stained with hematoxylin and eosin.
Measurements of testosterone, LH and FSH
After blood collection, sera were separated and stored at 220uC.
Serum testosterone was measured using a commercial kit (Deme-
ditec Diagnostics, Germany) while FSH and LH were measured by
ELISA as previously described [40]. The inter coefficient of variance
(CV) was 12% for LH and FSH at 2.5 ng/ml and 1.2 ng/ml. The
intra CV was ,10% for LH and FSH at 0.1 ng/ml to 10 ng/ml.
The inter CVwas 10.9% for Testosterone at 2.5 ng/ml and 8.9% at
6.0 ng/ml. The intra CV was ,8% for Testosterone at 0.1 ng/ml
to 25 ng/ml.
Tubule Permeability Study
Testes were collected from Amh-Cre;iDTR animals 7 days after
treatment with DTX at pnd50. The interstitium of the testes was
injected with 15 ml of 10 mg/ml EZ-Link Sulfo-NHS-LC-Biotin
(Pierce, Rockford, IL) freshly diluted in PBS containing 0.01 M
MgCl2 and the testes were left on ice for 30 min. The contralateral
testis was injected with vehicle (0.01 M MgCl2 in PBS) as a
control. After incubation, the testes were fixed in Bouins for 6
hours, embedded in paraffin and processed for immunohisto-
chemistry as above.
Figure Handling
Figures were compiled using Adobe Photoshop CS6 and Adobe
Illustrator CS6 (Adobe System Inc., Mountain View, CA, USA).
Statistical analysis
Data were analysed using Student T test, one-way ANOVA
with the appropriate post hoc tests (Turkey’s multiple comparison
or Dunnet’s tests), Bartlett’s test or Chi-square test. Specific details
for each experiment are provided in figure legends. Graph Prism
version 5 (GraphPad Software Inc., San Diego, CA, USA) or
Minitab (Minitab Inc, State College, PA, USA) were used for
analysis. When required, data were normalised by box-cox
transformation. Values are expressed as means 6 SEM.
Results
Sertoli cell specific ablation in Amh-Cre;iDTR mice
To determine the fundamental role of Sertoli cells in the adult
testis we bred an Amh-Cre+/2 line [41] to mice carrying a Cre-
inducible simian HBEGF (iDTR) [42] (Figure 1A), and confirmed
that iDTR expression was restricted to Sertoli cells (Figure 1B).
Pilot studies showed that injection of 100 ng DTX has no effect on
the testes from Wild-type (WT), Amh-Cre+/2, or iDTR+/2
animals, but resulted in complete ablation of Sertoli cells in
Amh-Cre+/2;iDTR+/2 mice (Figure S1), with no evidence of off-
target effects in other organs (Figure S2). Following this
demonstration Amh-Cre+/+;iDTR+/+ mice treated either with
100 ng DTX or vehicle were used for the remainder of the study
to minimize animal numbers (Figure 1C). Treatment of adult
pnd50) AMH-Cre;iDTR mice with 100 ng DTX led to a visible
reduction in testis size when examined 7, 30 and 90 days post
injection (Figure 1D–F). Histological and immunohistochemical
examination of the testes showed Sertoli cell apoptosis and a
striking reduction in Sertoli cell numbers (defined by immunolo-
calisation of SOX9) at 7 days post injection (Figure 1G, H).
Measurement of the Sertoli cells markers Dhh, Wt1 and Fshr by
qPCR showed that expression was significantly reduced in the
same period, with expression of all of these markers remaining low
or absent up to one year after Sertoli cell ablation, (Figure 1I),
consistent with complete loss of SOX9 immunolocalisation
throughout this period (Figure 1H). Stereological analysis of the
testes showed that less than 1% of the normal Sertoli cell
population remained in the testis 30 days after DTX injection.
Furthermore, circulating FSH concentrations were significantly
increased both 30 days and one year post Sertoli cell ablation
(consistent with removal of the Sertoli cell-dependent hypotha-
lamic-pituitary-gonadal-axis negative feedback loop) (Figure 1J).
Together these data confirmed successful acute ablation of the
Sertoli cell population from the adult testis in the iDTR model.
Ablation of Sertoli cells in adulthood induces loss of all
germ cell-types, but does not impact on testicular
architecture
Ablation of Sertoli cells at pnd50 led to a significant reduction in
testis weight, 7, 30, 90 days and one year later (Figure 2A). This
was primarily due to extensive loss of germ cells, which normally
make up more than 80% of testicular cell types in the adult animal
(Figure 2B). Seven days after DTX treatment the tubules
remained intact and spermatogonia and spermatocytes were
present although many of the spermatocytes and spermatids were
undergoing apoptosis (Figure 2C). By 30 days after DTX
treatment (pnd80) the lumen of most tubules was either acellular
or contained only elongated spermatids (black arrow; Figure 2C).
One year after DTX injection, the tubular structure of the testes
remained morphologically intact although all of the tubules had
shrunk and all contained calcium salt deposits. Elongated
spermatids remained in some of the tubules, largely trapped
within the calcium salts (Figure 2D). This loss of germ cells
following Sertoli cell ablation was confirmed by loss of gene
transcripts associated with specific germ cell stages (Stra8
spermatogonia, Dkkl1 spermatocyte, and Ptm2 spermatid) (Fig-
ure 2E). Apoptotic loss of germ cells in situ was reflected in the
significant reduction in numbers of spermatozoa present in the
cauda epididymis 30 days after Sertoli cell ablation (Figure 2F). To
exclude the possibility that germ cell loss would complicate our
study of the somatic cell populations, we generated Stra8-Cre+/2;
iDTR+/2 mice, which target iDTR expression specifically to the
germ cell lineage (from pnd3) [43]. Injection of 100 ng of DTX at
pnd50 induced cell-specific ablation of germ cells. Similar to
mouse models of busulfan-mediated germ cell ablation [44,45], we
observed no gross somatic cell impact arising from germ cell loss
Figure 1. Sertoli cell-specific ablation in adulthood. (A) Amh-Cre;iDTR model. (B) DTR expression is restricted to Sertoli cells (scale bar: 50 mm).
(C) Schematic representation of experiments in this study showing the time points of ablation relative to testis development. DTX-induced testicular
atrophy (D) 7 days, (E) 30 days or (F) 1 year after injection in adulthood (scale bar: 500 m). (G) Immunolocalisation for CLEAVED CASPASE3 shows that
apoptosis is restricted to Sertoli and germ cells (scale bar: 50 mm). (H) SOX9 expression is reduced but is still present in occasional tubules 7 days post-
Sertoli cell ablation (arrowhead). However, SOX9 is completely absent 30 days post-Sertoli cell ablation (scale bar: 100 mm). (I) Sertoli cell ablation is
mirrored by a decrease in Sertoli cell specific transcript expression: Dhh, Fshr and Wt1 (one-way ANOVA n= 5–9, ***P,0.001). (J) Circulating FSH
concentrations at d80 (one-way ANOVA n= 9–12, *P,0.05, **P,0.01). d,days; yr,year; dtx, injected with toxin; veh: vehicle control.
doi:10.1371/journal.pone.0105687.g001
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Figure 2. Germ cell loss after Sertoli cell ablation in adulthood does not impact testicular architecture. (A) Testis weight is decreased at
all ages following Sertoli cell ablation in adulthood (T-test n = 8–12, ****P,0.0001). (B) Immunolocalization of DDX4 shows loss of Germ cells is
complete 30 days following Sertoli cell ablation (scale bar: 100 mm). (C) Testicular histology (2.5 mm resin sections stained with hematoxylin and
eosin) shows that intact tubules, containing spermatogonia, spermatocytes and spermatids, are present 7 days following Sertoli cell ablation
although many of the spermatocytes (red arrowhead) are undergoing apoptosis. By 30 days the lumen of most tubules are either acellular or contain
only elongated spermatids (black arrow). Low and high power pictures from treated animals are shown at each age. (D) Image on the right shows
that one year after ablation tubular architecture is retained although the seminiferous tubules contain only calcium deposits and some elongated
spermatids. The image on the left is a from a control, age-matched testis. (E) Expression of Germ cell markers Stra8 and Dkkl1 and Ptm2 (one-way
ANOVA n= 5–9, **P,0.05 ***P,0.001 ****P,0.0001). (F) Consistent with Germ cell loss, Cauda epididymides are devoid of spermatozoa and only
cellular debris remains 30 days post Sertoli cell ablation (arrowhead) (scale bar: 100 mm). d,days; yr,year; dtx, injected with toxin; veh: vehicle control.
doi:10.1371/journal.pone.0105687.g002
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(Figure 3) and Sertoli cell and Leydig cell numbers were not
significantly different to control (data not shown).
Sertoli cells regulate PTMC function in the adult testis
Following Sertoli cell ablation in the adult, a single PTMC
layer, with a normal appearance, remained present around most
tubules up to one year post ablation (arrowhead; Figure 4A).
Levels of transcripts encoding the PTMC functional markers
Cnn1 and Myh11 were significantly reduced, however, for up to
one year after Sertoli cell ablation (Figure 4B). Consistent with
this, immunohistochemical staining of Calponin and MYH11 was
clearly reduced following Sertoli cell ablation (Figure 4C).
However, the PTMC continued to express SMA and the
localization of laminin appeared normal, suggesting retention of
the basement membrane which maintains overall tubular structure
in these animals (Figure 4C). Immunolocalization of all of these
markers was unaffected in testicular blood vessels (Figure 4C). At
one-year post Sertoli cell ablation there was loss of integrity in the
connective tissue of the peritubular and interstitial region
(Figure 4D), suggesting remodeling takes place over the longer-
term. This re-modelling is likely to involve a number of cell types
including the PTMC and interstitial cells. Together these results
suggest that, while the presence of the basement membrane is
sufficient to retain PTMC fate for several months after Sertoli cell
ablation (as defined by SMA expression), the Sertoli cells are
required in the adult animal to maintain normal PTMC function.
The PTMC/basement membrane inhibits immune cell
infiltration of seminiferous tubules
The blood-testis barrier (BTB) acts to regulate movement of
substances into the seminiferous tubules and to prevent immune
cell invasion of the tubules. In adult (pnd80) mice with Sertoli cell
ablation, the PTMC layer remained intact in most tubules, which
allowed us to determine the contribution of the PTMC and
basement membrane to the BTB. Following biotin injection [46],
the PTMCs created no barrier to biotin infiltration of the
seminiferous tubules in the absence of Sertoli cells, consistent
with the essential role of Sertoli cells in controlling the BTB
(Figure 5A). To examine the possible function of the PTMC/
basement membrane in exclusion of immune cells from the
tubules, we bred Amh-Cre+/+;iDTR+/+ mice with CSFR-GFP
(MacGreen) mice [47] to generate Amh-Cre+/2;iDTR+/2;CSFR-
GFP+/2 mice. This permitted tracking of macrophages, following
Sertoli cell ablation, through macrophage expression of GFP.
Analysis confirmed that macrophage localization was largely
restricted to peritubular and interstitial spaces with penetration of
less than 1% of the total tubular sections observed despite the
presence of cellular debris in all tubules (Figure 5B). This suggests
that the PTMC plays a significant role in regulating immune cell
access to the seminiferous epithelium. It is of interest that where
macrophage invasion of the tubule did occur (Figure 5C asterisks),
PTMC morphology was disrupted (Figure 4A, arrows), although it
is not clear whether this was a cause or consequence of the
macrophage invasion. To complete the kinetic analysis of immune
cell response we determined relative expression of the inflamma-
tory cytokine Tnfa [48] at each age. Tnfa expression was maximal
30 days post Sertoli cell ablation and fell to baseline levels by 90
days post ablation, consistent with resolution of the immune
response (Figure 5D).
Sertoli cell ablation in the adult mouse leads to a marked
reduction in Leydig cell number
Abundant Leydig cells remained in the interstitial tissue 7 days
after DTX injection and the cells appeared normal. By 30 days
after injection Leydig cells remained present singly or in groups
throughout the interstitium but the nuclei of these cells often had
an altered, elongated shape and the cytoplasm was vacuolated
and/or reduced in size (Figure 6A), which suggested they may be
undergoing apoptosis. This was confirmed through immunohisto-
chemical localization of Cleaved Caspase 3 (Figure 6B). Measure-
ment of Leydig cell numbers using the optical disector method
showed that there was no change in cell number 7 days after
Sertoli cell ablation but, by 30 days, Leydig cell number had
reduced significantly to 37% of control and to 25% of control by
90 days post-ablation. There was no further change in Leydig cell
number up to one-year post Sertoli cell ablation (Figure 6C)
Figure 3. Germ cell-specific cell ablation in adulthood does not
impact testicular architecture. Injection of DTX at pnd50 in Stra8-
Cre+/2;DTR+/2 mice induces specific Germ cell ablation (DDX4
immunolocalization). Testis architecture is unaffected and key testicular
somatic cells remain present - Sertoli cell (SOX9), PTMC (SMA), and
Leydig cell (HSD3B) (scale bar: 100 mm).
doi:10.1371/journal.pone.0105687.g003
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suggesting a stable threshold had been reached. Immunohisto-
chemistry confirmed that Leydig cells were largely lost from the
interstitial tissue and were only retained in the subcapsular region
and around the rete testis (Figure 6D). Those Leydig cells that
remained around the rete and subcapsular regions appeared to be
histologically normal when observed by light microscopy. At 90 or
365 days after DTX injection, Leydig cell distribution was similar
to that after 30 days although cells were more sparse in the
Figure 4. Sertoli Cells regulate PTMC function in adulthood. (A) Testicular histology (2.5 mm resin sections stained with hematoxylin and
eosin) shows a single layer of PTMC is retained around seminiferous tubules (red arrowhead) 30 days after Sertoli cell ablation at pnd50 although
some disruption of the PTMC layer can be noted (red arrows, associated with a small number of macrophage-infiltrated tubules) (scale bar: 100 mm).
(B) Expression of PTMC markers Cnn1 and Myh11 (one-way ANOVA n=5–9, **P,0.05, ***P,0.001). (C) SMA, Calponin (functional marker), laminin
(basement membrane) and MYH11 expression is retained 90 days following Sertoli cell ablation at pnd50. Disruption of SMA, Calponin, laminin and
MYH11 is observed one year following ablation (scale bar: 100 mm), although they remain unaffected in testicular vasculature (inset). (D) Consistent
with loss of PTMC function a fibrotic phenotype (PSR staining) develops one year following Sertoli cell-ablation (scale bar: 100 mm). d,days; yr,year;
dtx, injected with toxin; veh: vehicle control.
doi:10.1371/journal.pone.0105687.g004
Sertoli Cell Function in the Adult Testis
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interstitium. Together these data show that Sertoli cells are
fundamentally required for retention of the Leydig cell population
in the adult testis.
Basal circulating testosterone is maintained but peak
levels are lost after Sertoli cell ablation
Despite the significant reduction in Leydig cell number, average
circulating testosterone concentrations were not significantly
different from control animals at any time-point following Sertoli
cell ablation (Figure 7A), and seminal vesicle weights (Figure 7B)
Figure 5. The PTMC/basement membrane inhibits immune cell
infiltration of seminiferous tubules. (A) Biotin is prevented from
entering the adluminal compartment by the Blood-Testis-Barrier in
control animals. Conversely, 30 days post Sertoli cell ablation at pnd50,
and despite the continued presence of the PTMC layer, biotin
penetrates throughout the intratubular space. MgCl2: vehicle control.
(B) Immunolocalization of macrophages (GFP) at 30 days following
ablation at pnd50 using Amh-Cre+/+;iDTR+/+;CSFR-GFP mice (GFP
antibody) shows that very few tubules are infiltrated by macrophages
(red arrowhead). Macrophages are mainly present in the interstitium
(arrow) or surrounding tubules (white arrowhead). (C) Sections from
resinembeded testis highlighting the rare intra-tubular macrophage
infiltration (asterisks). (D) Relative expression of the inflammatory
cytokine Tnfa at key ages following Sertoli cell ablation at pnd50 (one-
way ANOVA n= 5–9, **P,0.01) (scale bar: 100 mm). d,days; yr,year; dtx,
injected with toxin; veh: vehicle control.
doi:10.1371/journal.pone.0105687.g005
Figure 6. Sertoli cell ablation in adulthood induces apoptotic
loss of Leydig cells. (A) Testicular histology on 2.5 mm resin sections
(stained with hematoxylin and eosin) shows altered Leydig cell
morphology 30 days after Sertoli cell ablation at pnd50. Leydig cells
show increased vacuolization of the cytoplasm (red arrowhead), while
some cells have an altered nuclear shape (red arrow) or reduced
cytoplasmic volume after Sertoli cell ablation (white arrowhead). (B)
Immunolocalisation for CLEAVED CASPASE3 shows Leydig cells
undergo apoptosis (red arrowhead) (scale bar: 25 mm). (C) Total Leydig
cell number per testis at key time-points following Sertoli cell ablation
at pnd50 (one-way ANOVA n=3–13, ****P,0.0001). (D) Leydig cells
(HSD3B) are restricted to the rete (red arrowhead) and subcapsular
region (red arrow) following Sertoli cell ablation at pnd50. (scale bar:
100 mm). d,days; yr,year; dtx, injected with toxin; veh: vehicle control.
doi:10.1371/journal.pone.0105687.g006
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(a biomarker of circulating testosterone) did not differ from
controls. Circulating testosterone levels in mice are pulsatile,
however [49], and so there is often huge variation between
animals depending on whether or not they were killed (and the
blood sample collected) during a pulse. It is clear from Figure 7A
that the variance in testosterone levels is greater in the vehicle
controls than in the Sertoli cell-ablated animals (P,0.001 by
Bartlett’s test) which suggests that there is attenuation of the
testosterone pulses after Sertoli cell ablation. To examine this is
more detail, data from all control animals (n = 64) and all Sertoli
cell-ablated animals (n = 65), including data from animals with
prepubertal Sertoli cell ablation [21], is shown in Figure 8. In
control animals, two populations are apparent, animals with a
basal level of testosterone and animals with an elevated level
measured at some point during a testosterone pulse. It can also be
seen, however, that the high ‘‘pulse’’ levels of testosterone are
largely absent in the Sertoli cell-ablated animals (this difference is
significant (P,0.008) by Chi-square testing). Mean LH levels were
higher at all times after Sertoli cell ablation although this
difference was only significant at one year (Figure 7C). As with
testosterone, however, circulating LH levels in the mouse are
pulsatile and when data from all animals is examined individually
(Figure 8) it is clear that pulse levels of LH are higher after Sertoli
cell ablation (P = 0.008, Chi-Square testing).
Discussion
The adult Leydig cells differentiate from progenitor cells in the
peritubular region of the testis with a possible contribution also
coming from perivascular cells [50]. In the mouse this process
starts between seven and ten days after birth [51] and, while the
initial differentiation appears to be gonadotrophin-independent,
development of a normal, functional adult Leydig cell population
is critically dependent on LH [18–20,52,53]. The whole process is
also dependent on the presence of the Sertoli cells; ablation of
Sertoli cells in the neonatal period leads to a .90% loss of adult
Leydig cells with mature cells only forming near the rete testis
where Sertoli-like cells remain [21]. Once formed, activity of the
adult Leydig cells is dependent on LH and osteocalcin and in the
absence of either hormone Leydig cell activity is markedly reduced
although cell numbers are largely maintained [27,54]. Results
reported here now show for the first time that the Sertoli cells are
essential for maintenance of the adult Leydig cell population. The
Sertoli cells, therefore, are critical regulators of the two major
functions of the adult testis - germ cell development and androgen
secretion.
There is no direct contact between Sertoli cells and Leydig cells
and loss of adult Leydig cells following Sertoli cell ablation would
suggest that there must be a Sertoli cell-derived factor(s) that is
required to maintain the Leydig cells. This factor may act directly
on the Leydig cell or may be mediated through the PTMC, which
have been previously shown to regulate Leydig cell function [55].
The Sertoli cells are essential for maintenance of the PTMC
phenotype in neonatal mice and loss of the PTMC is associated
with loss of adult Leydig cell precursor cells and failure of adult
Leydig cell development [21]. In the adult testis the PTMC
remain intact after Sertoli cell ablation but there is a clear change
in activity, which may at least contribute to loss of the adult Leydig
cell population. The nature of the factor or factors derived from
the Sertoli cells (and, possibly, the PTMC) and acting on Leydig
cell maintenance is unclear at present. Previous studies have
identified the presence of FSH-dependent Sertoli cell factors that
can regulate Leydig cell activity [56–59], although their nature is
also unknown and it is unclear whether they can act to maintain
adult Leydig cell numbers. Earlier studies have also shown,
however, that adult Leydig cell number is reduced in adult mice
lacking FSH-receptors [60], which would be consistent with a link
between these FSH-dependent factors and results reported here.
The maintenance of basal circulating testosterone, despite loss
of 75% of the Leydig cell population following Sertoli cell ablation,
suggests that the remaining Leydig cells may have become
hyperactive. This effect is also seen following neonatal Sertoli cell
ablation [21] and may be a result of altered LH pulse amplitude or
may indicate that Sertoli cells normally act to constrain Leydig cell
activity. A number of studies, mostly using in vitro systems, have
reported the presence of Sertoli cell–derived factors, which inhibit
Leydig cell function, although their nature is unknown [61–63]. It
should be noted that the Sertoli cells have also been postulated to
secrete factors which stimulate Leydig cell function such as DHH
[64] and so effects of Sertoli cell ablation on remaining Leydig cells
would be a balance between loss of stimulatory and inhibitory
factors. Despite maintenance of basal testosterone levels, the
Leydig cells were unable to generate testosterone pulses and so
may be working at close to maximum activity. Loss of testosterone
pulses had no effect on SV weight but consequences for other
aspects of androgen-dependent growth and function remain
uncertain at this point. Levels of FSH were doubled one year
Figure 7. Adult Leydig Cell functionally compensate following
Sertoli cell ablation in adulthood. (A) Serum testosterone (one-way
ANOVA n=7–14) (B) Seminal Vesicle weight (T-test n = 8–12) and (C)
Luteinizing Hormone concentrations (T-test n = n=7–14, **P,0.01) in
adulthood following Sertoli cell ablation at different ages. d,days;
yr,year; dtx, injected with toxin; veh: vehicle control; SV:seminal vesicle.
doi:10.1371/journal.pone.0105687.g007
Figure 8. Changes in hormone pulsatility following SC
ablation. Individual values for serum testosterone in vehicle-treated
(A) and DTX-treated (C) animals. Individual values for serum LH in
vehicle treated (B) and DTX treated (D) animals. Red dotted line
indicates the mean of control animals. d,days; yr,year; dtx, injected with
toxin; veh: vehicle control.
doi:10.1371/journal.pone.0105687.g008
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after Sertoli cell ablation which is a similar increase to that seen in
castrate animals [65,66]. This is likely to reflect loss of feedback
control from the Sertoli cells (inhibins, follistatin) and loss of
testosterone pulses.
Previous studies have shown that the adult Leydig cell
population will regenerate from stem cells following ablation by
the cytotoxic drug EDS [67,68]. The question then arises why
Leydig cells do not appear to regenerate following loss in this
model of Sertoli cell ablation. One likely explanation is that
regeneration requires the presence of the Sertoli cells, which our
previous studies have shown to be essential for normal develop-
ment of the adult Leydig cell population [21]. It has also been
shown that Leydig cell regeneration following EDS is associated
with high LH and inhibition of LH levels prevents cell
differentiation [69]. Since LH levels do not rise markedly after
Sertoli cell ablation this may also contribute to failure of Leydig
cell regeneration. Interestingly, loss of Leydig cells from the testis
following Sertoli cell ablation was spatially localized, with
remaining cells mainly located adjacent to the rete testis or in
the subcapsular region (Figure 7). The maintenance of Leydig cells
around the rete testis following Sertoli cell ablation would be
consistent with the Sertoli cell-like activity of the rete epithelial
cells seen in neonatal mice [21] and suggests that these cells may
retain a degree of Sertoli cell functional activity beyond puberty. It
is less clear why Leydig cells are also retained or re-localize to the
sub-capsular region of the testis following Sertoli cell ablation. It
has been reported that mice with a gain of function mutation in
the LH receptor gene show Leydig cell hyperplasia most
frequently in the capsular region [70]. This would support the
hypothesis that these subcapsular cells are different to the
parenchymal Leydig cells either because of their localization or
because they are a separate population of adult Leydig cells [71].
Either way, these subcapsular Leydig cells do not require Sertoli
cell support and, if localization is the major influence, the presence
of larger blood vessels in this area may be a contributory factor
either through interaction with the vascular smooth muscle cells or
through an altered growth factor environment.
As might be expected, Sertoli cell ablation in adult animals led
to a rapid immune response in the testis with an increase in
interstitial macrophages apparent by seven days and an increase in
cytokine levels, which peaked at 30 days post-ablation. It is known
that the resident testicular interstitial macrophages form a close
physical and functional relationship with the Leydig cells [72,73]
and so changes in Leydig cell number/function following Sertoli
cell ablation could also be related to changes in the macrophage
population. It is unlikely, however, that this is a major contributing
factor on its own to the marked loss of Leydig cells following
Sertoli cell ablation as increased testicular macrophage numbers in
other situations (e.g. orchitis [74], BTB disruption [75]) do not
lead to marked changes in the adult Leydig cell population.
Cytokines can increase or decrease Leydig cell function [76],
which may contribute to changes in Leydig cell activity after
Sertoli cell ablation but there is no evidence that they can induce
Leydig cell apoptosis. Finally, the immune response in the testis is
largely finished by 90 days after Sertoli cell-ablation in the adult
but this is not associated with any marked change in Leydig cell
function compared to 30 days.
The BTB is generated largely by the presence of specialised
junctions between adjacent Sertoli cells near to the basement
membrane [77] and it acts to restrict movement into the
seminiferous tubules and to allow the Sertoli cells to regulate the
internal environment of the tubules. The BTB develops in rodents
between pnd15 and pnd19 [78–80] and formation of the barrier is
an essential step in the development of spermatogenesis, any delay
preventing the onset of meiosis [78,81]. The contribution that the
PTMC makes to the BTB is probably species dependent and early
studies showed that in rodents the PTMC would act as a partial
barrier to the penetration of lanthanum to the tubular epithelium
[82,83]. Studies reported here, however, show that in the absence
of the Sertoli cells the PTMC fail to act as a barrier to the larger
substance biotin. This would suggest that one function of the
Sertoli cell is to maintain the barrier properties of the PTMC in
the mouse. It is also clear, however, that even in the absence of the
Sertoli cell the PTMC and underlying ECM is sufficient to exclude
macrophages in most tubules. This answers a long-standing
question in testis immunology, indicating that the PTMC is likely
to contribute to the immune privilege of the seminiferous tubules.
The mouse testis contains about 14 seminiferous tubules [84] and
so the low level of macrophage invasion seen in testis sections
suggests that, where infiltration occurs, it is a localized event and
does not occur along the length of the tubule.
In a previous study a gradual loss of Sertoli cells was shown over
a one-year period in mice lacking BCL2L2 (BCLW) [85]. This was
associated with an initial hyperplasia of the adult Leydig cells
lasting until 8 months followed by Leydig cell apoptosis so that by
one year of age few Leydig cells remained in the testis [85]. What
has not been clear in these studies was whether loss of Leydig cells
was associated directly with loss of the Sertoli cells or was due to
lack of BCL2L2 expression in the Leydig cells or another cell type.
Results from our current study now show that loss of Leydig cells
in BCL2L2-null animals is probably due, at least partly, to loss of
the Sertoli cell population. The phase of Leydig cell hyperplasia
seen in the BCL2L2-null mice did not, however, occur in the
Sertoli cell-ablation model used here and may, therefore, have
been a result of changes in Sertoli cell activity in the BCL2L2-null
mice prior to cell death. Alternatively, the prolonged period of
Sertoli cell death in BCL2L2-null mice may have been associated
with increased LH levels, which counteracted the initial loss of
Sertoli cell trophic factors to cause Leydig cell proliferation.
Recent studies have shown that in mice lacking Dicer in the Sertoli
cells there is abnormal development of the Sertoli cells followed by
cell loss over a 6-month period [86,87]. Following Sertoli cell
apoptosis in these animals the testes contained abundant Leydig
cells [87] but Leydig cell number was not measured and so it is not
clear whether there was an overall change in Leydig cell number.
Data from this study should be read in context with previous
results from our group showing developmental changes in the
testis following Sertoli cell ablation in the fetus or in neonatal/
prepubertal life [21]. The two studies have now examined different
aspects of Sertoli cell function, their role in development of the
testis and their role in maintenance of adult testicular function.
The developmental studies have shown that during fetal and
neonatal life the Sertoli cells are essential for the retention of
tubular structure and for maintenance of PTMC phenotype [21].
As the animal ages into puberty [21] or adulthood (this study),
however, the Sertoli cells are no longer required to maintain
tubular structure or PTMC differentiated function, presumably
because the basement membrane has developed to the point
where it can support these functions. Both this study and the
earlier developmental study [21] have shown that the Sertoli cells
are essential at all ages for the maintenance of all germ cell
populations, including spermatogonia. This may be due to
maintenance of the specialized environment of the tubule lumen
and is consistent with the absolute requirement for the Sertoli cells
in order to retain a solute barrier (described here). The
relationship between the Sertoli cells and the adult Leydig cells
can also be traced through both studies. At puberty, differentiation
of the adult Leydig cell population requires the presence of the
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Sertoli cells [21] and, once formed, these Leydig cells continue to
require the Sertoli cells in order to prevent degeneration (this
study). Therefore, while the function and role of the Sertoli cells
changes during development and in adulthood, the cells remain
critical at all time for normal testicular morphology, structure and
activity.
The Sertoli cells are recognized as the primary regulators of
testis development [2] and this study now shows that they continue
to regulate the two major functions of the testis, germ cell
development and androgen production, into adulthood. As such,
therefore, this study represents a significant change in our
understanding of events underpinning life-long support of testis
function. In addition, the suggestion that trophic support from the
Sertoli cell acts to maintain adult Leydig cell number and function
may be an important factor in understanding life-long health in
the male. In the human, numbers of Sertoli cells fall as men age
[7] and ageing is also associated with a reduction in both number
[15,16] and function [17] of the adult Leydig cell population. In
addition, while the concept of an ‘andropause’ remains conten-
tious, the evidence linking (lower) testosterone levels to risk of
cardiovascular disease [1], diabetes, obesity and metabolic
syndrome [2–5], has become firmly established in recent years,
and low testosterone is a predictor of early death [6]. The data
from this study now suggests that the reduction in Sertoli cell
number may be a major contributory cause of Leydig cell loss in
the ageing testis. This highlights the importance of the Sertoli cells
as both a potential target for endocrine disrupting chemicals or
lifestyle influences (e.g. obesity) which could impact on Leydig cell
function, and also as a novel target for potential therapeutics
aimed at maintaining normal androgen profiles during ageing.
Since the Sertoli cells are also under critical regulation by FSH
and by androgen, long-term changes in the levels of these
hormones may also contribute to more widespread effects on
testicular function and health through changes in Sertoli cell
activity.
Supporting Information
Figure S1 Diphtheria toxin-mediated Sertoli cell-specif-
ic ablation. (A) Inheritance of iDTR and Cre Recombinase
transgenes relative to testicular histology following DTX injection.
Inheritance of both transgenes is required for Sertoli cell-
specific ablation. 697 bp= iDTR-negative; 253 bp= iDTR-posi-
tive; 320 bp=Cre-negative (positive control for PCR amplifica-
tion); 110 bp=Cre-positive; Marker (m); Water (w). (scale bar:
100 mm).
(TIF)
Figure S2 Diphtheria-toxin does not cause increased
apoptosis in other organs. (A) Histology of non-gonadal
tissues (Heart Brain Adrenal Kidney Liver and Spleen) demon-
strating no off-target effects 7 or 30 days post-DTX injection (scale
bar: 200 mm). (B) Immunostaining for CLEAVED CASPASE 3
protein in adrenal and kidney of adult Amh-Cre;iDTR vehicle or
DTX-treated mice 7 days after ablation (scale bar: 100 mm). DTX
treatment to ablate Sertoli cells engenders no off-target apoptosis
in other tissues. d,days; dtx, injected with toxin; veh: vehicle
control.
(TIF)
Table S1 Primers used for Genotyping and qRT-PCR.
(DOCX)
Table S2 Details of Antibodies and detection methods
used.
(DOCX)
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